Found 78 matching trials
SIRT With Tremelimumab and Durvalumab for Resectable HCC
PHASE1The goal of this research study is to evaluate the safety and tolerability ...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma
PHASE2Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Location
Multiple Locations
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
PHASE1This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Location
Research Facility
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
PHASE1This is a feasibility study in patients with localized or metastatic soft t...
Location
Monter Cancer Center (Northwell Health)
Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma
NAThis study will evaluate the safety and efficacy of durvalumab in combinati...
Location
Multiple Locations
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
PHASE2Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Location
Local Institution - 113
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
PHASE2This is a Phase 2 clinical trial, which tests two investigational drugs: TP...
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
PHASE2In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Location
Stanford University
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
PHASE2The purpose of this study is to determine whether JNJ-90301900 added to con...
Location
Moores Cancer Center at UC San Diego Health
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
PHASE1This trial is designed to investigate the safety, response rates and surviv...
Location
The Second Affiliated Hospital of Guangzhou Medical University